Literature DB >> 3615089

Campylobacter pyloridis-associated primary gastritis in children.

B Drumm, A O'Brien, E Cutz, P Sherman.   

Abstract

Campylobacter pyloridis are spiral-shaped Gram-negative bacteria that have recently been associated with gastritis and peptic ulcer diseases in adults. The organisms have been identified in biopsy specimens of the gastric antrum by staining sections with silver stain. To determine the frequency of colonization of the antral mucosa with C pyloridis in association with gastritis in childhood, we retrospectively reviewed 53 cases in patients (mean age 11.9 years) in whom upper endoscopy with antral biopsy was performed for the evaluation of symptoms referable to the upper gastrointestinal tract. A silver impregnation method was used to detect the presence of C pyloridis. Nineteen of 53 antral biopsy specimens showed evidence of mucosal inflammation. Ten of these 19 patients had no apparent predisposing etiology for gastritis, and six of these ten had C pyloridis identified on antral biopsies. Nine of the 19 patients had secondary causes of gastric inflammation (two gastroduodenal Crohn disease, two eosinophilic gastroenteritis, four drug related, and one dys-gamma-globulinemia and lymphonodular hyperplasia). In contrast, none of these nine patients had C pyloridis demonstrated on antral biopsies. Silver stain for C pyloridis was negative in all 34 of the 53 children who had normal antral histologic findings. C pyloridis was not demonstrated by silver stain on any of the duodenal sections, although eight of the 19 children with gastritis and nine of the 34 children with normal antral histologic findings had histologic evidence of duodenal inflammation. We conclude that C pyloridis is associated with primary antral gastritis but not with secondary gastritis in the pediatric population.

Entities:  

Mesh:

Year:  1987        PMID: 3615089

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  21 in total

Review 1.  Helicobacter pylori.

Authors:  B Drumm
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

Review 2.  Helicobacter pylori disease in childhood.

Authors:  U Blecker
Journal:  Eur J Pediatr       Date:  1996-09       Impact factor: 3.183

Review 3.  Campylobacter pylori and gastroduodenal disease.

Authors:  G E Buck
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

4.  Helicobacter pylori and associated duodenal ulcer.

Authors:  C K Yeung; K H Fu; K Y Yuen; W F Ng; T M Tsang; F J Branicki; H Saing
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

5.  Helicobacter pylori-related gastroduodenal disease in children. Diagnostic utility of enzyme-linked immunosorbent assay.

Authors:  M S Glassman; S Dallal; S H Berezin; H E Bostwick; L J Newman; G I Perez-Perez; M J Blaser
Journal:  Dig Dis Sci       Date:  1990-08       Impact factor: 3.199

6.  In vitro surface properties of the newly recognized gastric pathogen Helicobacter pylori.

Authors:  J I Smith; B Drumm; A W Neumann; Z Policova; P M Sherman
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

7.  Campylobacter gastritis simulating Menetrier's disease by upper gastrointestinal radiography.

Authors:  J C Chaloupka; B B Gay; D Caplan
Journal:  Pediatr Radiol       Date:  1990

8.  Primary antral gastritis in young American children. Low prevalence of Helicobacter pylori infections.

Authors:  J D Snyder; S C Hardy; G M Thorne; B Z Hirsch; D A Antonioli
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

9.  Helicobacter pylori infection in children. Is there specific symptomatology?

Authors:  R Reifen; I Rasooly; B Drumm; K Murphy; P Sherman
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

10.  The prevalence of Helicobacter pylori serum antibodies in children with recurrent abdominal pain.

Authors:  S B van der Meer; P P Forget; R J Loffeld; E Stobberingh; R H Kuijten; J W Arends
Journal:  Eur J Pediatr       Date:  1992-11       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.